Jeff Yass’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Jeff Yass’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-130,434	Closed	-$307K	–	13620
2024 Q3	$307K	Buy	130,434 +105,558	+424%	+$213K	﹤0.01%	9554
2024 Q2	$21.9K	Sell	24,876 -238,311	-91%	-$491K	﹤0.01%	11646
2024 Q1	$1.08M	Buy	263,187 +101,322	+63%	+$453K	﹤0.01%	6714
2023 Q4	$947K	Buy	161,865 +47,542	+42%	+$250K	﹤0.01%	7115
2023 Q3	$589K	Buy	114,323 +68,250	+148%	+$320K	﹤0.01%	7851
2023 Q2	$222K	Buy	+46,073	New	+$159K	﹤0.01%	10068

Jeff Yass's AUGX Position: Q4 2024 in Review

Jeff Yass sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 130,434 shares — an estimated $307K sold.

Jeff Yass first reported a position in AUGX in Q2 2023 and held it in 6 quarters. The position peaked at $1.08M in Q1 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Jeff Yass reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Jeff Yass sold 130,434 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $307K.
Jeff Yass first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
Jeff Yass's Augmedix, Inc. Common Stock position peaked at $1.08M in Q1 2024.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.